These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24768148)

  • 1. Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β).
    Cole EL; Shao X; Sherman P; Quesada C; Fawaz MV; Desmond TJ; Scott PJ
    Nucl Med Biol; 2014 Jul; 41(6):507-12. PubMed ID: 24768148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosynthesis and preliminary PET evaluation of glycogen synthase kinase 3β (GSK-3β) inhibitors containing [(11)C]methylsulfanyl, [(11)C]methylsulfinyl or [(11)C]methylsulfonyl groups.
    Kumata K; Yui J; Xie L; Zhang Y; Nengaki N; Fujinaga M; Yamasaki T; Shimoda Y; Zhang MR
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3230-3. PubMed ID: 26067173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel
    Zhong Y; Yang S; Cui J; Wang J; Li L; Chen Y; Chen J; Feng P; Huang S; Li H; Han Y; Tang G; Hu K
    Mol Pharm; 2021 Mar; 18(3):1277-1284. PubMed ID: 33492962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).
    Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):245-9. PubMed ID: 21115250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer's Disease:
    Giglio J; Fernandez S; Martinez A; Zeni M; Reyes L; Rey A; Cerecetto H
    J Med Chem; 2022 Jan; 65(2):1342-1351. PubMed ID: 34464131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery.
    Bernard-Gauthier V; Mossine AV; Knight A; Patnaik D; Zhao WN; Cheng C; Krishnan HS; Xuan LL; Chindavong PS; Reis SA; Chen JM; Shao X; Stauff J; Arteaga J; Sherman P; Salem N; Bonsall D; Amaral B; Varlow C; Wells L; Martarello L; Patel S; Liang SH; Kurumbail RG; Haggarty SJ; Scott PJH; Vasdev N
    J Med Chem; 2019 Nov; 62(21):9600-9617. PubMed ID: 31535859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Vidal B; Karpenko IA; Liger F; Fieux S; Bouillot C; Billard T; Hibert M; Zimmer L
    Nucl Med Biol; 2017 Dec; 55():1-6. PubMed ID: 28917111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of [
    Jia J; Yi L; Xia Z; Yang M; Qiu D; Zhao Z; Peng Z
    Bioorg Med Chem Lett; 2023 May; 88():129263. PubMed ID: 37004924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
    Vasdev N; Garcia A; Stableford WT; Young AB; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5270-3. PubMed ID: 16202587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.
    Khanfar MA; Asal BA; Mudit M; Kaddoumi A; El Sayed KA
    Bioorg Med Chem; 2009 Aug; 17(16):6032-9. PubMed ID: 19616957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel potent and highly selective glycogen synthase kinase-3β (GSK3β) inhibitors for Alzheimer's disease: design, synthesis, and characterization of pyrazines.
    Berg S; Bergh M; Hellberg S; Högdin K; Lo-Alfredsson Y; Söderman P; von Berg S; Weigelt T; Ormö M; Xue Y; Tucker J; Neelissen J; Jerning E; Nilsson Y; Bhat R
    J Med Chem; 2012 Nov; 55(21):9107-19. PubMed ID: 22489897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and in Vivo Evaluation of [
    Prabhakaran J; Zanderigo F; Sai KKS; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Mintz A; Mann JJ; Kumar JSD
    ACS Chem Neurosci; 2017 Aug; 8(8):1697-1703. PubMed ID: 28485573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Initial in Vivo Studies with [(11)C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3.
    Li L; Shao X; Cole EL; Ohnmacht SA; Ferrari V; Hong YT; Williamson DJ; Fryer TD; Quesada CA; Sherman P; Riss PJ; Scott PJ; Aigbirhio FI
    ACS Med Chem Lett; 2015 May; 6(5):548-52. PubMed ID: 26005531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.
    Bernard-Gauthier V; Aliaga A; Aliaga A; Boudjemeline M; Hopewell R; Kostikov A; Rosa-Neto P; Thiel A; Schirrmacher R
    ACS Chem Neurosci; 2015 Feb; 6(2):260-76. PubMed ID: 25350780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Zhang P; Hu HR; Bian SH; Huang ZH; Chu Y; Ye DY
    Eur J Med Chem; 2013 Mar; 61():95-103. PubMed ID: 23047001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of [
    Hu K; Patnaik D; Collier TL; Lee KN; Gao H; Swoyer MR; Rotstein BH; Krishnan HS; Liang SH; Wang J; Yan Z; Hooker JM; Vasdev N; Haggarty SJ; Ngai MY
    ACS Med Chem Lett; 2017 Mar; 8(3):287-292. PubMed ID: 28337318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
    Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
    Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of thieno[3,2-c]pyrazol-urea derivatives as potent glycogen synthase kinase 3β inhibitors based on the DFG-out conformation.
    Yan N; Liu HY; Kong TT; Kong ZH; Li LY; Ma X; Zeng YL; Wang MJ; Tang LQ; Zhang CM; Liu ZP; Liu C
    Bioorg Med Chem Lett; 2024 Nov; 112():129932. PubMed ID: 39182737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel
    Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
    J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.